Community Health Systems Inc
COMMUNITY HEALTH SYSTEMS INC is classified under Healthcare / Medical Equipment & Supplies and appears not currently profitable on the latest normalized snapshot.
Business. Community Health Systems Inc (NYSE: CYH) is a healthcare company primarily engaged in the medical devices industry. The firm operates within the Medical Equipment, Supplies & Distribution industry group, focusing on the sale of medical equipment and supplies. Specific details regarding its operating segments and geographic presence are not provided. The company is listed on the New York Stock Exchange under the ticker symbol CYH.
Analyst recommendations
9 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Community Health Systems Inc (NYSE: CYH) is a healthcare company primarily engaged in the medical devices industry. The firm operates within the Medical Equipment, Supplies & Distribution industry group, focusing on the sale of medical equipment and supplies. Specific details regarding its operating segments and geographic presence are not provided. The company is listed on the New York Stock Exchange under the ticker symbol CYH.
COMMUNITY HEALTH SYSTEMS INC (CYH) is currently classified as Medical Devices within Medical Equipment & Supplies (Healthcare). Classification confidence: 0.97 (rule-based classification). Capital structure on the latest snapshot: total assets 13,180,000,000 USD, total equity -1,454,000,000, short-term debt 0, long-term debt 10,127,000,000. Net cash position is approximately -9,415,000,000 USD. Self-calculated market cap is 392,498,101 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 2,965,000,000, gross profit 0, operating income 281,000,000, net income -58,000,000. Return on equity ~-35.0%. Return on assets ~3.9%. Operating-cash-flow to net-income ratio is 1.07. Risk profile from automated assessment: liquidity risk medium, dilution risk medium. Flags: Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Recent news context: [TRIGGER] 8-K: 8-K (sec_8k_material) on CYH — filing_type=8-K; max_severity=medium; ignored_items=['7.01', '9.01']; material_items=['2.02']; all_items_found=['2.02', '7.01', '9.01']; severity_per_code={'2.02': 'medium'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001193125-26-312454). Additional context: 8-K: filing_type=8-K; max_severity=medium; ignored_items=['7.01', '9.01']; material_items=['2.02']; all_items_found=['2.02', '7.01', '9.01']; severity_per_code={'2.02': 'medium'}; contributing_watchers=sec_8k_material.
- Observed GAAP P/E is about 0.77x.
- Return on equity is about -35.0%.
- Debt to equity is about -6.96x.
- [TRIGGER] 8-K: 8-K (sec_8k_material) on CYH — filing_type=8-K; max_severity=medium; ignored_items=['7.01', '9.01']; material_items=['2.02']; all_items_found=['2.02', '7.01', '9.01']; severity_per_code={'2.02': 'medium'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001193125-26-312454)
- Companyfacts coverage was partial; recent filing facts backfilled intangible_assets.
- 10-Q 0001108109 false Q1 --12-31 http://fasb.org/us-gaap/2025#AssetImpairmentCharges http://fasb.org/us-gaap/2025#AssetImpairmentCharges P10Y 2021 2022 0.06875 0.06875 5.25 5.25 0.0475 0.0475 .10875 .10875 10.750 10.750 9.750 9.750 0.06875 0.06875 0.06125 0.06125 http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2025#LongTermDebtNoncurrent http://fasb.org/us-gaap/2025#LongTermDebtNoncurrent 1 http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt975Due2034Member 2026-03-31 0001108109 2026-04-16 0001108109 cyh:CedarParkRegionalMedicalCenterMember 2025-12-31 0001108109 us-gaap:EmployeeStockOptionMember 2025-12-31 0001108109 cyh:ShorePointHealthPuntaGordMember 2025-12-31 0001108109 cyh:NorthwestHealthPhysiciansSpecialtyHospitalMember 2025-01-01 2025-12-31 0001108109 cyh:OtherMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2026-03-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:AblFacilityAndOtherDebtMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2026-01-01 2026-03-31 0001108109 cyh:PerformanceBasedAwardsGrantedOnOrAfterMarch12018Member cyh:ChiefExecutiveOfficerAndChiefFinancialOfficerMember cyh:RestrictedStockPerformanceBasedUnitsMember 2026-03-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2025-12-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2025-03-01 2025-03-01 0001108109 cyh:SiloamSpringsArkansasMember cyh:NorthwestMedicalCenterMember 2026-05-03 0001108109 cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member cyh:SeniorSecuredNotesMember 2026-03-31 0001108109 us-gaap:LetterOfCreditMember cyh:AssetBasedLoanFacilityMember 2026-01-01 2026-03-31 0001108109 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-12-31 0001108109 us-gaap:RetainedEarningsMember 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:MeritHealthMadisonMember 2025-01-01 2025-12-31 0001108109 us-gaap:CommonStockMember 2025-12-31 0001108109 cyh:AdjustmentForCarryingValueOfOtherLongLivedAssetsAtUnderperformingHospitalsMember 2026-01-01 2026-03-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-02-02 2026-02-02 0001108109 cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member cyh:SeniorSecuredNotesMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-03-31 0001108109 us-gaap:LetterOfCreditMember cyh:AmendedAndRestatedABLCreditAgreementMember 2024-06-05 0001108109 cyh:MedicaidMember 2025-01-01 2025-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2026-03-31 0001108109 cyh:MedicareMember 2025-01-01 2025-03-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member cyh:SeniorSecuredNotesMember 2025-01-01 2025-12-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2026-03-31 0001108109 cyh:FinanceLeaseAndFinancingObligationsMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2025-12-31 0001108109 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001108109 us-gaap:NoncontrollingInterestMember 2024-12-31 0001108109 cyh:RegionalHospitalOfScrantonMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt975Due2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 us-gaap:DomesticCountryMember 2026-01-01 2026-03-31 0001108109 cyh:WilkesBarreGeneralHospitalMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001108109 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2025-03-01 2025-03-31 0001108109 cyh:OtherProbableContingenciesMember us-gaap:PendingLitigationMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2026-03-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:BuildingAndBuildingImprovementsMember 2026-03-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001108109 2025-10-01 2025-12-31 0001108109 cyh:SpringdaleArkansasMember cyh:NorthwestMedicalCenterMember 2026-05-03 0001108109 cyh:ShorePointHealthPuntaGordMember 2025-01-01 2025-12-31 0001108109 cyh:MeritHealthMadisonMember 2025-12-31 0001108109 cyh:AdjustmentForCarryingValueOfOtherLongLivedAssetsAtUnderperformingHospitalsMember 2025-01-01 2025-03-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:FurnitureAndFixturesMember 2025-12-31 0001108109 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 us-gaap:CommonStockMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2026-01-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2026-01-01 2026-03-31 0001108109 us-gaap:CommonStockMember 2024-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2026-01-01 2026-03-31 0001108109 2026-01-01 2026-03-31 0001108109 cyh:LakeNormanRegionalMedicalCenterMember 2025-01-01 2025-12-31 0001108109 cyh:PlanTwoThousandNineMember 2026-01-01 2026-03-31 0001108109 2025-01-01 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt1075Due2033Member 2026-03-31 0001108109 cyh:MedicareManagedCareMember 2026-01-01 2026-03-31 0001108109 cyh:MeritHealthBiloxiAndMeritHealthMadisonMember 2026-01-01 2026-03-31 0001108109 cyh:ManagedCareAndOtherThirdPartyPayorsMember 2025-01-01 2025-03-31 0001108109 cyh:ShorePointHealthPortCharlotteMember 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:DebtInstrumentRedemptionPeriodMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-02-02 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2026-01-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-12-31 0001108109 cyh:TennovaHealthcare-ClarksvilleMember 2026-01-01 2026-03-31 0001108109 srt:MaximumMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001108109 stpr:TN cyh:MeritHealthBiloxiMember 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001108109 cyh:AblFacilityAndOtherDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:ShorePointHealthPortCharlotteMember 2025-12-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:FurnitureAndFixturesMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtSixDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:RestrictedStockAndRestrictedStockUnitsMember 2026-01-01 2026-03-31 0001108109 cyh:AblFacilityCustomaryCovenantsMember cyh:AssetBasedLoanFacilityMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtSixDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 us-gaap:NoncontrollingInterestMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 2024-12-31 0001108109 us-gaap:RetainedEarningsMember 2025-03-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2025-01-01 2025-03-31 0001108109 cyh:AssetBasedLoanFacilityMember 2025-12-31 0001108109 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001108109 cyh:RestrictedStockPerformanceBasedUnitsMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2026-03-31 0001108109 2024-07-01 2024-09-30 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2025-12-31 0001108109 cyh:HospitalsSoldOrDeemedHeldForSaleMember 2025-01-01 2025-03-31 0001108109 2025-12-31 0001108109 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001108109 srt:MaximumMember 2025-01-01 2025-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001108109 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-01 2026-03-31 0001108109 cyh:AssetBasedLoanFacilityMember 2026-03-31 0001108109 cyh:OtherMember 2025-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2026-03-31 0001108109 cyh:MosesTaylorHospitalMember 2026-01-01 2026-03-31 0001108109 cyh:CrestwoodMedicalCenterMember cyh:HuntsvilleAlabamaMember 2026-01-20 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2026-03-31 0001108109 cyh:MosesTaylorHospitalMember 2026-03-31 0001108109 cyh:MedicareManagedCareMember 2025-01-01 2025-03-31 0001108109 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2026-01-01 2026-03-31 0001108109 us-gaap:NoncontrollingInterestMember 2026-03-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2026-03-01 2026-03-31 0001108109 cyh:AmendedAndRestatedABLCreditAgreementMember 2024-06-05 0001108109 cyh:CrestwoodMedicalCenterMember cyh:HuntsvilleAlabamaMember us-gaap:SubsequentEventMember 2026-04-01 2026-04-01 0001108109 srt:MaximumMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAtSixDue2029Member 2025-12-31 0001108109 cyh:AblFacilityAndOtherDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2025-01-01 2025-12-31 0001108109 cyh:MedicaidMember 2026-01-01 2026-03-31 0001108109 us-gaap:RetainedEarningsMember 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001108109 us-gaap:EmployeeStockOptionMember 2025-09-30 0001108109 cyh:LakeNormanRegionalMedicalCenterMember 2025-12-31 0001108109 cyh:AblFacilityCustomaryCovenantsMember cyh:AssetBasedLoanFacilityMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-01-01 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt1075Due2033Member 2025-12-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2025-03-01 2025-03-01 0001108109 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2025-12-31 0001108109 cyh:TennovaHealthcare-ClarksvilleMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt1075Due2033Member 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-03-31 0001108109 cyh:CedarParkRegionalMedicalCenterMember 2025-01-01 2025-12-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2026-02-02 0001108109 us-gaap:CommonStockMember 2025-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember 2026-03-01 2026-03-01 0001108109 cyh:SharedServiceCenterMember 2026-01-01 2026-03-31 0001108109 cyh:RestrictedStockAndRestrictedStockUnitsMember 2026-03-31 0001108109 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001108109 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001108109 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001108109 cyh:SelfPayRevenueMember 2025-01-01 2025-03-31 0001108109 cyh:OtherProbableContingenciesMember us-gaap:PendingLitigationMember 2026-03-31 0001108109 cyh:MeritHealthBiloxiMember 2025-01-01 2025-12-31 0001108109 cyh:NorthwestHealthPhysiciansSpecialtyHospitalMember 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2025-01-01 2025-12-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2025-01-01 2025-12-31 0001108109 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001108109 us-gaap:RestrictedStockMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt6Due2029Member 2025-01-01 2025-12-31 0001108109 cyh:MedicareMember 2026-01-01 2026-03-31 0001108109 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001108109 cyh:NorthwestMedicalCenterMember cyh:JohnsonArkansasMember 2026-05-03 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 2025-03-31 0001108109 cyh:TennovaHealthcareMember 2025-01-01 2025-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt975Due2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:ManagedCareAndOtherThirdPartyPayorsMember 2026-01-01 2026-03-31 0001108109 cyh:PerformanceBasedAwardsGrantedOnOrAfterMarch12018Member cyh:RestrictedStockPerformanceBasedUnitsMember cyh:OtherSeniorExecutivesMember 2026-03-01 2026-03-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 cyh:FinanceLeaseAndFinancingObligationsMember 2025-12-31 0001108109 us-gaap:EmployeeStockOptionMember 2026-03-31 0001108109 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001108109 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-12-31 0001108109 cyh:FinanceLeaseRightOfUseAssetsMember us-gaap:BuildingAndBuildingImprovementsMember 2025-12-31 0001108109 cyh:CrestwoodMedicalCenterMember us-gaap:SubsequentEventMember cyh:HuntsvilleAlabamaMember 2026-04-01 0001108109 cyh:SeniorSecuredNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-12-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:AblFacilityAndOtherDebtMember 2025-12-31 0001108109 us-gaap:RestrictedStockMember 2025-12-31 0001108109 cyh:RegionalHospitalOfScrantonMember 2026-01-01 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt975Due2034Member 2025-12-31 0001108109 cyh:WilkesBarreGeneralHospitalMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorNotesAt10875PercentDue2032Member 2025-12-31 0001108109 us-gaap:SeniorNotesMember cyh:SeniorNotesAt6875PercentDue2028Member 2026-03-31 0001108109 us-gaap:RestrictedStockUnitsRSUMember cyh:PlanTwoThousandNineMember srt:DirectorMember 2026-03-01 2026-03-01 0001108109 cyh:HospitalsSoldOrDeemedHeldForSaleMember 2026-01-01 2026-03-31 0001108109 cyh:OtherProbableContingenciesMember us-gaap:PendingLitigationMember 2026-01-01 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-01-01 2026-03-31 0001108109 us-gaap:RetainedEarningsMember 2024-12-31 0001108109 cyh:MeritHealthBiloxiMember 2025-12-31 0001108109 us-gaap:LetterOfCreditMember cyh:AssetBasedLoanFacilityMember 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAtSixDue2029Member 2026-03-31 0001108109 cyh:RedeemableNoncontrollingInterestsMember 2024-12-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001108109 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtNinePointSevenFiveZeroDue2034Member 2026-01-01 2026-03-31 0001108109 us-gaap:NoncontrollingInterestMember 2025-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt10875Due2032Member 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesAt525Due2030Member 2025-12-31 0001108109 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001108109 us-gaap:SeniorNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorNotesAt6875PercentDue2028Member 2026-03-31 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2026-03-31 0001108109 us-gaap:RestrictedStockMember 2026-03-31 0001108109 cyh:SelfPayRevenueMember 2026-01-01 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:SixPointEightSevenFivePercentageJuniorPrioritySecuredNotesDue2029Member 2026-01-01 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAt525Due2030Member 2026-03-31 0001108109 cyh:PlanTwoThousandNineMember 2026-03-31 0001108109 us-gaap:CarryingReportedAmountFairValueDisclosureMember cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2026-03-31 0001108109 cyh:JuniorPrioritySecuredNotesMember cyh:JuniorPrioritySecuredNotesAt6125PercentDue2030Member 2026-03-31 0001108109 cyh:BentonvilleArkansasMember cyh:NorthwestMedicalCenterMember 2026-05-03 0001108109 cyh:SeniorSecuredNotesMember cyh:SeniorSecuredNotesAtFourPointSevenFiveDue2031Member 2025-12-31 cyh:Hospital xbrli:pure cyh:Item xbrli:shares cyh:Segment cyh:Director iso4217:USD iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
Bull / Bear case
Generated · model-assistedCommunity Health Systems generated $1.49 billion in operating income for fiscal year 2025, demonstrating strong core profitability.
The company achieved a positive net income of $509 million in fiscal year 2025, marking a significant turnaround.
Free cash flow improved to $208 million in fiscal year 2025, providing liquidity for debt reduction and operations.
Return on invested capital of 17.2% suggests the company generates substantial value relative to its capital base.
High credit risk is flagged, compounded by a net debt to EBITDA ratio of 5.29, signaling leverage concerns.
Negative book value of -$4.1 billion indicates substantial accumulated losses eroding the company's equity base.
Medium liquidity risk is identified, suggesting potential challenges in meeting short-term financial obligations comfortably.
Revenue growth remained sluggish with a 0.6% CAGR from 2023 to 2025, limiting top-line expansion potential.
In focus — financials by report
Revenue $2.96B; Operating income $281.0M.
- ▍Revenue $2.96B
- ▍Operating income $281.0M
- ▍Net margin -2.0%
Revenue $9.38B; Operating income $1.04B.
- ▍Revenue $9.38B
- ▍Operating income $1.04B
- ▍Net margin 4.3%
Revenue $6.29B; Operating income $795.0M.
- ▍Revenue $6.29B
- ▍Operating income $795.0M
- ▍Net margin 4.3%
Revenue $12.48B; Operating income $1.49B.
- ▍Revenue $12.48B
- ▍Operating income $1.49B
- ▍Net margin 4.1%
Revenue $12.63B; Operating income $542.0M.
- ▍Revenue $12.63B
- ▍Operating income $542.0M
- ▍Net margin -4.1%
Revenue $12.63B; Operating income $542.0M.
- ▍Revenue $12.63B
- ▍Operating income $542.0M
- ▍Net margin -4.1%
Revenue $12.49B; Operating income $957.0M.
- ▍Revenue $12.49B
- ▍Operating income $957.0M
- ▍Net margin -1.1%
Revenue $12.49B; Operating income $957.0M.
- ▍Revenue $12.49B
- ▍Operating income $957.0M
- ▍Net margin -1.1%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
- Source documents mention dilution or offering risk.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Stock Units (SU) → Common StockDisposed 13 931exercise · 2026-06-30
- EVP-Clinical Operations & CMO · Stock Options (Right to Buy) → Common StockAcquired 30 000 @ $2,75grant · 2026-06-01
- EVP-Clinical Operations & CMO · Performance Based Restricted → Common StockAcquired 30 000grant · 2026-06-01
- Director · Restricted Stock Units → Common StockDisposed 46 950exercise · 2026-04-22
- Director · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 9 756exercise · 2026-03-01
- EVP, Operations & Development · Performance Based Restricted → Common StockDisposed 50 000exercise · 2026-03-01
- EVP, Operations & Development · Performance Based Restricted → Common StockAcquired 60 000grant · 2026-03-01
- EVP, Operations & Development · Stock Options (Right to Buy) → Common StockAcquired 30 000 @ $3,46grant · 2026-03-01
- SVP & CAO · Performance Based Restricted → Common StockAcquired 25 000grant · 2026-03-01
- SVP & CAO · Stock Options (Right to Buy) → Common StockAcquired 25 000 @ $3,46grant · 2026-03-01
- Pres,Chief Legal&Admin Officer · Performance Based Restricted → Common StockDisposed 30 000exercise · 2026-03-01
- Pres,Chief Legal&Admin Officer · Performance Based Restricted → Common StockAcquired 80 000grant · 2026-03-01
- Pres,Chief Legal&Admin Officer · Stock Options (Right to Buy) → Common StockAcquired 40 000 @ $3,46grant · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 19 933exercise · 2026-03-01
- Director · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 9 756exercise · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 9 756exercise · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 19 933exercise · 2026-03-01
- Director · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
- Director · Restricted Stock Units → Common StockAcquired 52 023grant · 2026-03-01
- Director · Restricted Stock Units → Common StockDisposed 20 906exercise · 2026-03-01
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Return On Equitynet_income / total_equity
- Enterprise Valuemarket_cap - net_cash
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Capex To Revenuecapital_expenditure / revenue
- COMMUNITY HEALTH SYSTEMS INC company facts · 2026-07-26
- COMMUNITY HEALTH SYSTEMS INC 10-Q 2026-04-22 · 2026-07-26
- COMMUNITY HEALTH SYSTEMS INC 10-K 2026-02-19 · 2026-07-26
- COMMUNITY HEALTH SYSTEMS INC 10-Q 2025-10-24 · 2026-07-26
- COMMUNITY HEALTH SYSTEMS INC 10-Q 2025-07-24 · 2026-07-26
- 8-K (sec_8k_material) on CYH · 2026-07-26
- Community Health Systems Inc Market data — analyst estimates · 2026-07-26
- Community Health Systems Inc Market data — ESG · 2026-07-26
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2024-06-300,00 %$31M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2025-12-310,00 %$29M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$5M
- Funds · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2024-12-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- Director · Common StockOther 13 930 · 2026-06-30
- EVP-Clinical Operations & CMO · Common StockOther 30 000 · 2026-06-01
- Director · Common StockOther 46 950 · 2026-04-22
- Director · Common StockOther 19 400 · 2026-03-02
- EVP, Operations & Development · Common StockOther 30 000 · 2026-03-01
- EVP, Operations & Development · Common StockOther 35 573 @ $3,46$123K · 2026-03-01
- SVP & CAO · Common StockOther 25 000 · 2026-03-01
- SVP & CAO · Common StockOther 1 188 @ $3,46$4K · 2026-03-01
- Pres,Chief Legal&Admin Officer · Common StockOther 30 000 · 2026-03-01
- Pres,Chief Legal&Admin Officer · Common StockOther 40 000 · 2026-03-01
- Pres,Chief Legal&Admin Officer · Common StockOther 24 922 @ $3,46$86K · 2026-03-01
- EVP & CFO · Common StockOther 30 000 · 2026-03-01
- EVP & CFO · Common StockOther 90 000 · 2026-03-01
- EVP & CFO · Common StockOther 23 610 @ $3,46$82K · 2026-03-01
- CEO · Common StockOther 156 240 · 2026-03-01
- CEO · Common StockOther 200 000 · 2026-03-01
- CEO · Common StockOther 96 896 @ $3,46$335K · 2026-03-01
- Director · Common StockOther 9 756 · 2026-03-01
- Director · Common StockOther 20 906 · 2026-03-01
- Director · Common StockOther 19 933 · 2026-03-01
- Director · Common StockOther 20 906 · 2026-03-01
- Director · Common StockOther 19 933 · 2026-03-01
- Director · Common StockOther 9 756 · 2026-03-01
- Director · Common StockOther 20 906 · 2026-03-01
- Director · Common StockOther 19 933 · 2026-03-01
Short positioning
Geographic breakdown
Intel & risk
no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)
- Narrative— → —medium
- Conclusion— → —medium
- Key takeaways— → —medium
- Company share pct— → —medium
Evidence & claims
From filings & derived data- Operating income (annual): USD 1.49BUnknown
- Current assets (annual): USD 3.23BUnknown
- Shares outstanding (annual): 138.63MUnknown
- Cost of revenue (annual): USD 1.86BUnknown
- Shareholders' equity (annual): USD -1.39BUnknown
- Cash & equivalents (annual): USD 260MUnknown
- Operating cash flow (annual): USD 543MUnknown
- Long-term debt (annual): USD 10.4BUnknown
- EPS (basic) (annual): USD-PER-SHARES 4Unknown
- Total liabilities (annual): USD 14.04BUnknown
- Total assets (annual): USD 13.2BUnknown
- Capex (annual): USD 335MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 4Unknown
- Net income (annual): USD 509MUnknown
- Current liabilities (annual): USD 2.21BUnknown
- Pre-tax income (annual): USD 724MUnknown
- Revenue (annual): USD 12.48BUnknown
- Operating cash flow (annual): USD 480MUnknown
- EPS (diluted) (annual): USD-PER-SHARES -4Unknown
- Capex (annual): USD 360MUnknown
- Total assets (annual): USD 14.05BUnknown
- Net income (annual): USD -516MUnknown
- Cost of revenue (annual): USD 1.95BUnknown
- Operating income (annual): USD 542MUnknown